ECONOMIC AND BUSINESS MODELS
32 AMR CONTROL 2015
References
1. US CDC Threat Report 2013: Antibiotic / Antimicrobial Resistance. http://
www.cdc.gov/drugresistance/threat-report-2013/ (accessed on January 10, 2015)
2. Antimicrobial Resistance in Developing Countries Sosa, A. de J., Byarugaba, D.K.,
Amabile, C., Hsueh, P.-R., Kariuki, S., Okeke, I.N. (Eds.), 2010, XXIII, 554 p. Springer.
3. Zar, H. J., S. A. Madhi, S. J. Aston, and S. B. Gordon. "Pneumonia in Low- and MiddleIncome
Countries: Progress and Challenges." Thorax (2013): 1-5.
4. Blomberg B, Manji KP, Urassa WK, et al. Antimicrobial resistance predicts death in
Tanzanian children with bloodstream infections: a prospective cohort study. BMC
Infectious Diseases 2007; 7:43.
5. Laxminarayan R, Bhutta ZA, Duse A, et al. "Chapter 55: Drug Resistance," in Jamison
DT, editor, Disease Control Priorities in Developing Countries, 2nd edition. New York:
Oxford University Press, 2006.
6. Gu, Bing, et al. "Comparison of the Prevalence and Changing Resistance to Nalidixic
Acid and Ciprofloxacin of Shigella between Europe-America and Asia-Africa from
1998 to 2009." International Journal of Antimicrobial Agents 40.1 (2012): 9-17.
7. Deguchi, Takashi, et al. "Emergence and Spread of Drug Resistant Neisseria
Gonorrhoeae." The Journal of Urology 184 (2010): 851-58.
8. Brenzel L, Wolfson LJ, Fox-Rushby J, Miller M, Halsey NA. Chapter 20: VaccinePreventable
Diseases. Disease Control Priorities in Developing Countries (2nd
Edition), ed. ed.new York: Oxford University Press, 2006, p. 397.
9. World Health Organization. The evolving threat of antimicrobial resistance: Options
for action. Geneva, Switzerland: WHO, 2012. Available at: http://whqlibdoc.who.int/
publications/2012/9789241503181_eng.pdf (accessed on January 10, 2015).
10. Cookson C. G8 ministers pledge to act on bacterial antibiotic resistance. Financial
Times, June 13, 2013. http://www.ft.com/cms/s/0/172341bc-d428-11e2-a46400144feab7de.html#axzz2gfdBG33I
(accessed on January 10, 2015)
11. Howell L, editor. Global Risks 2013, Eighth Edition. Geneva, Switzerland: World
Economic Forum, 2013
12. The Declaration of WAAAR - World Alliance Against Antibiotic Resistance, June 23,
2014, signed by 700 personalities from the medical world and a 100 scientific
societies. http://www.ac2bmr.fr/index.php/fr/declaration-waaar (accessed on January
10, 2015)
13. Ghafur A, Mathai D, Muruganathan A, Jayalal JA, Kant R, Chaudhary D, Prabhash K,
Abraham OC, Gopalakrishnan R, Ramasubramanian V, Shah SN, Pardeshi R, Huilgol A,
Kapil A, Gill J, Singh S, Rissam HS, Todi S, Hegde BM, Parikh P. "The Chennai
Declaration" Recommendations of "A roadmap- to tackle the challenge of
antimicrobial resistance" - A joint meeting of medical societies of India. Indian J Cancer
[Epub ahead of print] [cited 2013 Jul 15]. http://www.indianjcancer.com/
preprintarticle.asp?id=104065 (accessed on January 10, 2015)
14. Walsh T., et al. Dissemination of NDM-1 positive bacteria in the New Delhi
environment and its implications for human health: an environmental point prevalence
study. The Lancet, Vol 11, 5, May 2011. http://www.thelancet.com/
journals/laninf/article/PIIS1473-3099%2811%2970059-7/abstract (accessed on
January 10, 2015) Emergence of a new antibiotic resistance mechanism in India,
Pakistan, and the UK: a molecular, biological, and epidemiological study. Kumarasamy
K., Toleman M., Walsh T., http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2933358/
(accessed on January 10, 2015)
15. The Hague, The Netherlands, Ministerial meeting Antibiotic Resistance, 25-26 June
2014 http://www.who.int/drugresistance/netherlands_meeting_june_2014/en/
(accessed on January 10, 2015); and Oslo, Norway, Norwegian Institute of Public
Health, Nov.13-14 2014 "Commitments to the responsible use of antimicrobials",
meeting organized by the group "Diplomacy and Health" (Brazil, France, Indonesia,
Norway, South Africa http://www.fhi.no/artikler/?id=112149 (accessed on January
10, 2015)
16. Press release: (UK) Prime Minister warns of global threat of antibiotic resistance,
source, First published: 2 July 2014 https://www.gov.uk/government/news/primeminister-warns-of-global-threat-of-antibiotic-resistance
(accessed on January 10,
2015). The White House Blog http://www.whitehouse.gov/blog/2014/09/18/newexecutive-actions-combat-antibiotic-resistance-and-protect-public-health
(accessed
on January 10, 2015)
17. APUA Newsletter - Newsletter Vol. 30 No. 1. New Antibiotic Development: Barriers
and Opportunities in 2012. Spellberg, B. http://www.tufts.edu/med/apua/news/newsnewsletter-vol-30-no-1-2.shtml
(accessed on January 10, 2015)
18. Peláez, F., The historical delivery of antibiotics from microbial natural products -
Can history repeat?, Biochemical Pharmacology, 2006, http://www.sciencedirect.com/
science/article/pii/S0006295205006611 (accessed on January 10, 2015)
19. So AD, Gupta N, Brahmachari S, et al. Towards new business models for R&D for
novel antibiotics. Drug Resistance Updates 2011; 14:88-94. On page 89, "Seventy
screens conducted by GlaxoSmithKline (GSK) from 1995 to 2001 (67 HTS, three
whole-cell) produced five lead compounds, representing a mere 7% success rate.
GSK's experience is corroborated by Pfizer's 6.5% success rate in producing lead
compounds (personal communication Paul Miller, Pfizer)."
20. New Business Models for Sustainable Antibiotics, Chatham House report,
Outterson K., February 2014
http://www.chathamhouse.org/sites/files/chathamhouse/
public/Research/Global%20Health/0214sustainableantibiotics.pdf (accessed on
January 10, 2015)
21. Antibiotics Innovation Funding Mechanism (AIFM), a proposal shortlisted for
demonstration project by WHO's EURO region http://keionline.org/node/1832
(accessed on January 10, 2015). A funding mechanism in the AIFM is a special tax
levied on the use of the new antibiotics, as a way to replenish the fund for prizes and to
monitor and curb drug use.
22. Peláez, F., Op. cit.
23. Committee on Development and Intellectual Property, Fourteenth Session, Geneva,
November 10 to 14, 2014. World Intellectual Property Organization, 19 Sept. 2014,
http://www.wipo.int/edocs/mdocs/mdocs/en/cdip_14/cdip_14_inf_12.pdf (accessed on
January 10, 2015)
24. USA Sept. 18, 2014. Report to the President on combating antibiotic resistance,
Executive Office of the President President's Council of Advisors on Science and
Technology (PCAST) September 2014
http://www.whitehouse.gov/sites/default/files/microsites/ostp/pcast/pcast_carb_rep
ort_sept2014.pdf (accessed on January 10, 2015). And, "New Executive Actions to
Combat Antibiotic Resistance and Protect Public Health"
25. http://longitudeprize.org/challenge/antibiotics (accessed on January 10, 2015)
26. PCAST, USA Op. cit.
27. Harry T. Dykman, Patent Licensing within The Manufacturer's Aircraft Association
(MAA), 46 J. PAT. OFF. SOC'Y 646, 648 (1964)
28. http://www.wipo.int/research/en/ (accessed on January 10, 2015)
29. Global Forum for Health Research, Monitoring Financial Flows for Health Research,
MA Burke, SA Matlin, JJ Monot, yearly reports and meetings with the WHO.
http://announcementsfiles.cohred.org/gfhr_pub/m.htm (accessed on January 10,
2015).
30. Kristiansen C, America is losing biomedical research leadership to Asia, NIH Fogarty
International Center, Global Health Matters newsletter, January / February
2014 | Volume 13, Issue 1.
http://www.fic.nih.gov/news/globalhealthmatters/january-february2014/pages/spending-investment-biomedical-research-development.aspx
(accessed
on January 10, 2015).
31.unctad, Technology and Innovation Report 2012, Innovation, Technology and
South-South collaboration, Gehl Sampath P,
32. http://www.forbes.com/sites/matthewherper/2013/08/11/how-the-staggeringcost-of-inventing-new-drugs-is-shaping-the-future-of-medicine/
(accessed on January
10, 2015).
33. http://ca-biomed.org/pdf/media-kit/fact-sheets/cbradrugdevelop.pdf (accessed on
January 10, 2015).
34. According to the concept of the role of institutions in the expansion of science and
discoveries dear to the American Norwegian economic Thorstein Veblen.
35. WHO, Draft global action plan on antimicrobial resistance, 12 Dec. 2014, EB136/20
36. The tripartite collaboration WHO, FAO and OIE are developing standards for the
presence of antimicrobial agents and their residues in the environment, especially in
water, wastewater and food (including aquatic and terrestrial animal feed).
37. Phage therapy: the Escherichia coli experience, Harald Bruessow, Nestle´s Research
Centre, Microbiology (2005), 151, 2133-2140.
http://mic.sgmjournals.org/content/151/7/2133. (accessed on January 10, 2015)
38. European Union funded research on use of phages (viruses of bacteria) for patients
burn wound bacterial infections. http://www.phagoburn.eu/ (accessed on January 10,
2015). Phage therapies are also presently investigated extensively for animal health to